UAE Scores with International Drugmakers

The United Arab Emirates is gaining popularity as a manufacturing base for pharmaceuticals, according to the country’s health ministry.

Speaking to journalists at the recent Pharma in the GCC conference in Dubai, Amin Al Amiri, assistant undersecretary of Public Health Policy and Licensing at the UAE Ministry of Health, said the number of pharmaceutical manufacturing plants in the emirates is likely to more than double in the next five years to 34, from 16 at present.

The increase, Al Amiri said, reflects the UAE governments’ economic diversification efforts that are now beginning to bear fruit. The official said he expects three deals this year between international drug companies and domestic drug manufacturers.

In 2014, Dubai-based Globalpharma agreed to produce some of Sanofi’s generic medicines in the UAE. In the same year, Abu Dhabi’s Neopharma sealed a deal with Pfizer’s Wyeth arm to make medicines for pain management, cardiovascular diseases and women’s health. Julphar, the largest generic pharmaceutical manufacturer in the Middle East and North Africa region, has 13 production sites in the emirates.

Despite the crunch created by low oil prices and reduced government spending in the region, the UAE’s health budget is expected to remain steady for the next several years. Up to 2019, total healthcare expenditure is pegged to grow by nearly 8%, while spending on pharmaceutical products is set to rise by just over 8%.

Healthcare expenditure will increase despite oil prices coming down, Al Amiri asserted. In particular, he said, the health ministry will focus on tackling non-communicable diseases and changing lifestyles to reduce the incidence of diabetes and obesity.

The UAE’s healthcare and pharmaceutical markets continue to be the strongest in the region, according to US market research group Researchmoz Global. The group forecasts high single-digit combined annual growth rates over a 10-year forecast period, driven by high income levels and a large expatriate population.

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.